Future Health Receives $100 Million Investment from Rothschild Family, Partners with International NMN Pharmaceutical Group to Create World's First NMN Futures Product
United States - May 27, 2023 —
On May 18, 2023, Future Trends Group, the parent company of Future Health, entered into a major strategic partnership and held a grand signing ceremony with Future Health in Dubai on May 23, 2023. Rothschild Investment Corp. Under the agreement, Rothschild Investment Corp will invest $100 million into Future Trends Group, which will be used primarily for Future Health's global business expansion and technological innovation.
The Rothschild family not only occupies three board seats, but also assists Future Health in establishing a strategic partnership with the international NMN Pharmaceutical Group. The two companies will work together to launch the world's first NMN futures product in June 2023 to provide cutting-edge anti-aging solutions to wordlwide users, with an initial futures product subscription of $300 million.
This NMN product is manufactured using Japan's leading biological all-enzyme method to ensure its high purity and efficiency, while adding PQQ ingredients to enhance its efficacy and absorption. The product also features plant-based enteric capsules that reach directly into the intestinal tract for maximum release of NMN activity.
*Representative from International NMN Pharmaceutical Group and Future Health representative (first from left) signing site picture*
The new NMN product is one of the important results of our strategic cooperation with the Rothschild family and an important milestone in the development of Future Health, which greatly enhances Future Health's leadership and influence in the global anti-aging field.
This capital investment cooperation reflects Rothschild Investment's high recognition of Future Health, which not only brings strong financial and resource support to Future Health, but also shows high expectation for Future Health WEB3.0 project and innovative new products such as NMN futures.
About Rothschild Investment Corporation:
Rothschild & Co is one of the financial institutions still in operation by the Rothschild family, and is the legacy and continuation of this ancient financial family, currently focusing on private equity, asset management and other areas.
About Future Health:
Future Health is an innovative biopharmaceutical company driven by digital transformation, bringing together the world's top healthcare resources to create a global digital healthcare system. It was initiated by Chairman Mr Farzam and has invested heavily in the development of post-epidemic restoration products, with the ultimate mission of advancing the health industry for the benefit of all humans.
The core competitiveness of Future Health WEB 3.0: real people, real medicine, real profit!
Real people: The leader of Future Health WEB 3.0 and the founder of Future Trend Group, Chairman Mr Farzam, who will share his insights and experiences with you and lead you to higher achievements and wealth.
True medicine: The core products of Future Health WEB 3.0, stem cell recovery capsules with unique advantages after the epidemic, the international famous brand NMN, Pfizer and more international famous brands will be released and listed in the next three years, bringing the gospel to worldwide consumers.
True Profit: The core source of revenue for Future Health WEB 3.0 is the appreciation of Woodpecker WP tokens and dividends. Its dividends will be based on the income from innovative medicine development, operation and sales, through investment in futures of Woodpecker's series of post-epidemic restoration products;
Profit from strategic investment in futures products with the world's top health products, now with international brands NMN, Pfizer, and many more internationally known brands strategic investment in futures products! Lock future profits in advance and enjoy Future Health WEB 3.0 dividends.
Contact Info:
Name: Daisy
Email: Send Email
Organization: Future Health
Website: http://www.futurehealth.vip/
Release ID: 89098662
If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us. We will respond and rectify the situation in the next 8 hours.
